Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2014 4
2015 1
2016 1
2019 5
2020 1
2021 2
2022 2
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for xiaohua ci
Search for Xiaohu Ci instead (1 results)
Comparison of Outcomes between Fractional-Flow-Reserveand Angiography-Directed Intervention in Non-ST Elevation Acute Coronary Syndrome.
Jianjun Y, Xiaohua P, Xuemei T, Gang H, Hailong W. Jianjun Y, et al. J Coll Physicians Surg Pak. 2019 Mar;29(3):268-273. doi: 10.29271/jcpsp.2019.03.268. J Coll Physicians Surg Pak. 2019. PMID: 30823956 Review.
Compared with CA, the collection of the studies indicated that FFR had a lower incidence of myocardial infarction (MI) (OR, 0.61; 95% CI: 0.39-0.96; p <0.05). However, none showed important disparities in main adverse cardiovascular events (MACE, OR, 0.74; 95% CI …
Compared with CA, the collection of the studies indicated that FFR had a lower incidence of myocardial infarction (MI) (OR, 0.61; 95% CI …
Efficacy and Safety of SHR0302, a Highly Selective Janus Kinase 1 Inhibitor, in Patients with Moderate to Severe Atopic Dermatitis: A Phase II Randomized Clinical Trial.
Zhao Y, Zhang L, Ding Y, Tao X, Ji C, Dong X, Lu J, Wu L, Wang R, Lu Q, Goh AH, Liu R, Zhang Z, Zhang J. Zhao Y, et al. Am J Clin Dermatol. 2021 Nov;22(6):877-889. doi: 10.1007/s40257-021-00627-2. Epub 2021 Aug 9. Am J Clin Dermatol. 2021. PMID: 34374027 Free PMC article. Clinical Trial.

RESULTS: At week 12, IGA response was achieved in nine patients (25.7%; 90% confidence interval [CI] 13.6-37.9%; p = 0.022) in the SHR0302 4 mg group, 19 patients (54.3%; 90% CI 40.4-68.1%; p < 0.001) in the SHR0302 8 mg group, and two patients (5.7%; 90% CI

…
RESULTS: At week 12, IGA response was achieved in nine patients (25.7%; 90% confidence interval [CI] 13.6-37.9%; p = 0.022) in the SH …
High-Frequency US for BK Polyomavirus-associated Nephropathy after Kidney Transplant.
Yang D, Zhuang B, Wang Y, Huang G, Xu M, Lin M, Wang W, Huang G, Wang C, Xie X, Xie X. Yang D, et al. Radiology. 2022 Aug;304(2):333-341. doi: 10.1148/radiol.211855. Epub 2022 May 3. Radiology. 2022. PMID: 35503018
The AUC for predicting BKPyVAN according to subcapsular hypoechoic areas was 0.66 (95% CI: 0.55, 0.77), with a specificity of 92% (55 of 60 participants). ...The pooled specificity of subcapsular hypoechoic areas was 96% (21 of 22 participants), with an AUC of 0.67 (95% …
The AUC for predicting BKPyVAN according to subcapsular hypoechoic areas was 0.66 (95% CI: 0.55, 0.77), with a specificity of 92% (55 …
Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer.
Pignata S, Bookman M, Sehouli J, Miller A, Penson RT, Taskiran C, Anderson C, Hietanen S, Myers T, Madry R, Willmott L, Lortholary A, Thomes-Pepin J, Aghajanian C, McCourt C, Stuckey A, Wu X, Nishio S, Copeland LJ, He Y, Molinero L, Patel S, Lin YG, Khor VK, Moore KN. Pignata S, et al. Gynecol Oncol. 2023 Oct;177:20-31. doi: 10.1016/j.ygyno.2023.06.018. Epub 2023 Aug 23. Gynecol Oncol. 2023. PMID: 37625235 Clinical Trial.
RESULTS: After 38 months' median follow-up, the OS hazard ratio in the PD-L1-positive population was 0.83 (95% CI, 0.66-1.06; p = 0.13); median OS was not estimable with atezolizumab versus 49.2 months with placebo. The hazard ratio for OS in the ITT population was 0.92 (9 …
RESULTS: After 38 months' median follow-up, the OS hazard ratio in the PD-L1-positive population was 0.83 (95% CI, 0.66-1.06; p = 0.1 …
Hematologic changes predict clinical outcome in recovered patients with COVID-19.
Mao J, Dai R, Du RC, Zhu Y, Shui LP, Luo XH. Mao J, et al. Ann Hematol. 2021 Mar;100(3):675-689. doi: 10.1007/s00277-021-04426-x. Epub 2021 Feb 1. Ann Hematol. 2021. PMID: 33523290 Free PMC article.
However, changes of eosinophils (end hospitalization-baseline) (coefficients = 10.32; 95% CI = 1.03-19.60, P = 0.03) and basophils (Max - Min) (coefficients = 71.43; 95% CI = 8.55-134.31, P = 0.03) were independent predictors of delayed recovery in the hospital by t …
However, changes of eosinophils (end hospitalization-baseline) (coefficients = 10.32; 95% CI = 1.03-19.60, P = 0.03) and basophils (M …
Correlations Between Iron Status and Body Composition in Patients With Type 2 Diabetes Mellitus.
Zimiao C, Dongdong L, Shuoping C, Peng Z, Fan Z, Rujun C, Xiaohua G. Zimiao C, et al. Front Nutr. 2022 Jul 13;9:911860. doi: 10.3389/fnut.2022.911860. eCollection 2022. Front Nutr. 2022. PMID: 35911095 Free PMC article.
Serum iron was positively correlated with the occurrence of a high A/G ratio (A/G ratio 1) after the adjustment of confounding factors [an odds ratio (OR = 1.09, 95% CI, 1.02-1.19, p = 0.02)]. With receiver operating curve analysis, the cutoff value of serum iron for a hig …
Serum iron was positively correlated with the occurrence of a high A/G ratio (A/G ratio 1) after the adjustment of confounding factors [an o …
Vitamin D may not improve lipid levels: a serial clinical laboratory data study.
Ponda MP, Huang X, Odeh MA, Breslow JL, Kaufman HW. Ponda MP, et al. Circulation. 2012 Jul 17;126(3):270-7. doi: 10.1161/CIRCULATIONAHA.111.077875. Epub 2012 Jun 20. Circulation. 2012. PMID: 22718799 Free PMC article.
Compared with vitamin D deficient patients (<20 ng/mL), those with optimal levels (30 ng/mL) had lower mean total cholesterol (-1.9 mg/dL; 95% confidence interval [95% CI], -1.2 to -2.7; P<0.0001), lower low-density lipoprotein cholesterol (-5.2 mg/dL; 95% CI, …
Compared with vitamin D deficient patients (<20 ng/mL), those with optimal levels (30 ng/mL) had lower mean total cholesterol (-1.9 mg/dL …
Traditional Chinese medicine for the COVID-19 pandemic: An online cross-sectional survey among health care workers.
Jin X, Xu L, Lu C, Xue X, Liu X, Zhou Y, Hu X, Liu J, Pei X. Jin X, et al. Eur J Integr Med. 2023 Jun 27:102273. doi: 10.1016/j.eujim.2023.102273. Online ahead of print. Eur J Integr Med. 2023. PMID: 38620124 Free PMC article.
Flu-like symptoms were not associated with prevention, vaccination, or TCM. Frontline working experience (OR = 0.61, 95% CI: 0.46-0.80), good knowledge of post-COVID-19 syndrome (OR = 0.57, 95% CI: 0.39-0.84), Western medicine qualifications (OR = 2.41, 95% CI …
Flu-like symptoms were not associated with prevention, vaccination, or TCM. Frontline working experience (OR = 0.61, 95% CI: 0.46-0.8 …
Efficacy and Safety of Crisaborole Ointment 2% in Chinese Patients Aged ≥ 2 Years with Mild to Moderate Atopic Dermatitis.
Ma L, Tao X, Liu S, Cheng H, Fang R, Zhao Y, Cha A, Encinas GA, Zhou Y, Deng Y, Zhang J. Ma L, et al. Dermatol Ther (Heidelb). 2024 May;14(5):1229-1243. doi: 10.1007/s13555-024-01156-6. Epub 2024 May 15. Dermatol Ther (Heidelb). 2024. PMID: 38748345 Free PMC article.
A greater reduction in percent change from baseline in EASI total score at day 29 was shown in the crisaborole vs. vehicle group (least squares mean [LSM]: -66.34 [95% (confidence interval) CI -71.55 to -61.12] vs. -50.18 [95% CI -58.02 to -42.34]). Response rates f …
A greater reduction in percent change from baseline in EASI total score at day 29 was shown in the crisaborole vs. vehicle group (least squa …
Cytomegalovirus infection is associated with AML relapse after allo-HSCT: a meta-analysis of observational studies.
Zhang YL, Zhu Y, Xiao Q, Wang L, Liu L, Luo XH. Zhang YL, et al. Ann Hematol. 2019 Apr;98(4):1009-1020. doi: 10.1007/s00277-018-3585-1. Epub 2019 Jan 21. Ann Hematol. 2019. PMID: 30666434

Meta-analysis of 24 eligible cohort studies showed a significantly lower relapse risk after allo-HSCT in patients with CMV replication in acute myeloid leukemia (AML) (HR = 0.64, 95% CI, 0.50-0.83; P < 0.001) subgroup. However, CMV replication was associated with increa

…
Meta-analysis of 24 eligible cohort studies showed a significantly lower relapse risk after allo-HSCT in patients with CMV replication in ac …
21 results